Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
NLRP10 Regulates Keratinocyte Survival and Barrier Function
2026-04-30
The referenced study uncovers the essential role of NLRP10 in maintaining epidermal homeostasis by promoting keratinocyte survival and p63-dependent differentiation, directly linking genetic variation at the NLRP10 locus to impaired skin barrier function in atopic dermatitis. These insights establish NLRP10 as a promising target for therapeutic intervention aimed at restoring skin barrier integrity.
-
Lyso-Tracker Red in Mechanistic Lysosomal Assays: Beyond Mor
2026-04-29
Explore the advanced application of Lyso-Tracker Red for mechanistic lysosome analysis in live cells. This article reveals how the probe enables functional studies of lysosomal membrane dynamics, extending beyond traditional morphology and distribution assays.
-
PPM-18 and NF-κB Modulation: Advancing Sepsis and Inflammati
2026-04-29
Explore how PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) uniquely advances sepsis and immune modulation by targeting NF-κB/iNOS signaling. This article delivers novel protocol insights and links molecular mechanism to translational outcomes.
-
Triiodothyronine (T3, C6407): Reliable Thyroid Hormone for A
2026-04-28
Triiodothyronine (T3, SKU C6407) delivers consistent, high-purity thyroid hormone for metabolic and cellular assays. This article addresses common lab challenges and demonstrates, using scenario-driven analysis, how T3 from APExBIO optimizes reproducibility and data quality in thyroid hormone signaling pathway research.
-
Sunitinib: Multi-Targeted RTK Inhibitor in RCC Research Work
2026-04-28
Unlock the power of Sunitinib as a multi-targeted receptor tyrosine kinase inhibitor for in vitro and in vivo renal cell carcinoma studies. Explore advanced workflow enhancements, protocol guidance, and troubleshooting strategies—now with actionable insights from the latest combination therapy research.
-
PAD4-IN-2 TFA: Tumor-Selective PAD4 Inhibition and Immune Mo
2026-04-27
Unlock the full potential of PAD4-IN-2 TFA for targeted tumor inhibition and immune microenvironment modulation. This in-depth analysis reveals unique mechanistic insights and practical assay guidance beyond conventional reviews.
-
A Multimodal iPSC Platform for Cystic Fibrosis Drug Testing
2026-04-27
This study introduces a robust multimodal platform using iPSC-derived airway epithelial cells to model cystic fibrosis (CF) with a spectrum of CFTR mutations, enabling precise evaluation of genotype-specific drug responses. The work demonstrates how adapting established in vitro assays for iPSC-derived tissues can accelerate therapeutic discovery, particularly for rare CFTR variants lacking targeted treatments.
-
Enhanced A40926 Antibiotic Production via Engineered Nonomur
2026-04-26
This study details a dual strategy involving genetic engineering and medium optimization to significantly boost production of the glycopeptide antibiotic A40926 in Nonomuraea gerenzanensis. The findings advance scalable antibiotic biosynthesis for research and potential clinical applications.
-
Reserpine (N1867): Technical Guidance for Neuropharmacology
2026-04-25
Reserpine (SKU N1867) enables rigorous neurotransmitter depletion and antihypertensive mechanism studies by providing a high-purity, workflow-validated compound. Researchers should use this product within well-defined experimental parameters and avoid long-term solution storage to ensure consistency. Not suitable for diagnostic or medical applications.
-
Estradiol-ERα Signaling Restores CD4+ T Cells After Hemorrha
2026-04-24
This study demonstrates that 17β-estradiol (E2) normalizes splenic CD4+ T lymphocyte function after hemorrhagic shock by suppressing endoplasmic reticulum stress via ERα and GPR30, but not ERβ. The findings highlight specific estrogen receptor pathways in immunomodulation following trauma, providing mechanistic clarity for future endocrine and immune research.
-
Curcumin Suppresses NLRP3-Mediated Pyroptosis in Endothelial
2026-04-24
This study demonstrates that curcumin inhibits hydrogen peroxide-induced pyroptosis in human umbilical vein endothelial cells (HUVECs) by targeting the NLRP3 inflammasome. The findings clarify the mechanistic basis for curcumin’s protective effects in endothelial dysfunction, highlighting translational opportunities for inflammatory disease research.
-
Canagliflozin Remodels Mitochondria in Diabetic Mouse Kidney
2026-04-23
This study reveals that canagliflozin, a selective SGLT2 inhibitor, not only lowers glucose but also remodels mitochondrial structure and improves bioenergetic function in proximal tubular cells of hypertensive–diabetic mice. These findings provide mechanistic insight into renal protective effects, expanding the therapeutic relevance of SGLT2 inhibitors in kidney disease research.
-
L-Alanyl-L-Glutamine: Enhancing Intestinal Barrier Research
2026-04-23
L-Alanyl-L-glutamine stands apart as a stable, absorption-enhancing dipeptide that optimizes intestinal barrier workflows and experimental reproducibility. This article details applied protocols, troubleshooting strategies, and comparative advantages, anchoring the molecule's role as a research catalyst for mucosal protection and inflammation attenuation.
-
GLI2 Drives Tumor Immune Evasion via WNT and Prostaglandin S
2026-04-22
This study establishes GLI2 as a central regulator of tumor-mediated immune evasion and resistance to immunotherapy by coordinating WNT ligand secretion and prostaglandin synthesis. These mechanisms promote recruitment of immunosuppressive myeloid cells and impair anti-tumor immunity, revealing actionable targets for combination cancer therapies.
-
Lanabecestat (AZD3293): Protocols & Precision in Alzheimer’s
2026-04-22
Lanabecestat (AZD3293) stands out as a potent, blood-brain barrier-penetrant BACE1 inhibitor, empowering Alzheimer’s disease researchers with synaptic-sparing modulation of amyloid-beta production. This article unpacks applied workflows, assay optimization strategies, and troubleshooting tips, translating the latest reference findings into actionable guidance for robust, reproducible experiments.